2 years ago
LBPH
AnalystsPatrick TrucchioPatrick Trucchio's Stock Forecasts
AnalystsPatrick Trucchio
Analyst Ranking
Top 3%
#107 out of 5272 analysts
Average Return
+18.48%
Win Rate
43%177 out of 412
Risk vs Reward
Poor
Good
Patrick Trucchio's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alto Neuroscience IncANRO | +954.78% | $2.30 | $24.26 | 2025-06-26 - 2026-05-08 | Buy |
Alto Neuroscience IncANRO | +896.90% | $2.26 | $22.53 | 2025-04-07 - 2026-04-06 | Buy |
Longboard Pharmaceuticals IncLBPH | +410.35% | $6.86 | $35.01 | 2023-08-07 - 2024-08-06 | Buy |
Longboard Pharmaceuticals IncLBPH | +404.91% | $7.33 | $37.01 | 2023-07-11 - 2024-07-10 | Buy |
Sangamo Therapeutics IncSGMO | +388.69% | $0.44 | $2.16 | 2023-11-06 - 2024-11-05 | Buy |
Patrick Trucchio Analyst Color
Get additional color on Patrick Trucchio's coverage of popular stocks
2 years ago
ALT
2 years ago
HELP
4 years ago
VIR
Patrick Trucchio's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Assembly Biosciences IncASMB | 1 | Buy | $50.00 | +68.12% | Assumes | 9 months ago |
Altimmune IncALT | 19 | Buy | $12.00 | +288.35% | Reiterates | 9 months ago |
Alnylam Pharmaceuticals IncALNY | 27 | Buy | $570.00 | +93.19% | Maintains | 9 months ago |
Compass Pathways PLCCMPS | 15 | Buy | $40.00 | +303.63% | Maintains | 9 months ago |
Ataibeckley IncATAI | 20 | Buy | $15.00 | +272.21% | Maintains | 9 months ago |
Alto Neuroscience IncANRO | 2 | Buy | $10.00 | -58.78% | Reiterates | 10 months ago |
Invivyd IncIVVD | 19 | Buy | $5.00 | +233.33% | Reiterates | 10 months ago |
Sangamo Therapeutics IncSGMO | 25 | Buy | $10.00 | +8,595.65% | Reiterates | a year ago |
Silence Therapeutics PLCSLN | 24 | Buy | $75.00 | +976.04% | Reiterates | a year ago |
Immunocore Holdings PLCIMCR | 21 | Buy | $100.00 | +238.07% | Reiterates | a year ago |
Uniqure NvQURE | 15 | Buy | $70.00 | +153.07% | Reiterates | a year ago |
Oncolytics Biotech IncONCY | 18 | Buy | $5.00 | +461.80% | Reiterates | a year ago |
Precision Biosciences IncDTIL | 16 | Buy | $60.00 | +680.23% | Reiterates | a year ago |
Arrowhead Pharmaceuticals IncARWR | 23 | Buy | $80.00 | +10.06% | Reiterates | a year ago |
Gh Research PLCGHRS | 15 | Buy | $40.00 | N/A | Reiterates | a year ago |
Voyager Therapeutics IncVYGR | 10 | Buy | $30.00 | N/A | Reiterates | a year ago |
Harmony Biosciences Holdings IncHRMY | 6 | Buy | $70.00 | N/A | Reiterates | a year ago |
Beam Therapeutics IncBEAM | 8 | Buy | $80.00 | N/A | Reiterates | a year ago |
Milestone Pharmaceuticals IncMIST | 19 | Buy | $10.00 | N/A | Maintains | a year ago |
Gossamer Bio IncGOSS | 16 | Buy | $10.00 | N/A | Reiterates | a year ago |
Definium Therapeutics IncDFTX | 17 | Buy | $55.00 | N/A | Reiterates | a year ago |
Vir Biotechnology IncVIR | 22 | Buy | $110.00 | N/A | Reiterates | a year ago |
Bright Minds Biosciences IncDRUG | 2 | Buy | $85.00 | N/A | Reiterates | a year ago |
Cybin IncHELP | 16 | Buy | $150.00 | N/A | Maintains | a year ago |
Longboard Pharmaceuticals IncLBPH | 14 | Hold | $60.00 | N/A | Downgrades | 2 years ago |
Freeline Therapeutics Holdings PLCFRLN | 8 | Hold | $6.50 | N/A | Downgrades | 2 years ago |
Q32 Bio IncQTTB | 5 | Buy | $360.00 | N/A | Reiterates | 3 years ago |
Reunion Neuroscience IncREUN | 3 | Buy | $20.00 | N/A | Reiterates | 3 years ago |
Benitec Biopharma IncBNTC | 2 | Buy | $68.00 | N/A | Maintains | 4 years ago |
F Star Therapeutics IncFSTX | 4 | Hold | $7.00 | N/A | Downgrades | 4 years ago |
Arena Pharmaceuticals IncARNA | 2 | Hold | $100.00 | N/A | Downgrades | 4 years ago |
Allakos IncALLK | 2 | Buy | $20.00 | N/A | Maintains | 4 years ago |
Flexion Therapeutics IncFLXN1 | 2 | Hold | $10.00 | N/A | Downgrades | 5 years ago |
Mondaycom LtdMNDY | 1 | Buy | $340.00 | N/A | Maintains | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.